ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Approximately 52% of Ph-positive CML cases co-express p210BCR-ABL1 and p190BCR-ABL1 transcripts, with the other 48% exclusively expressing p210BCR-ABL1 [44].